Golden
Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim is a pharmaceutical company.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Amr Youssef

Employee



Aaron Graham

Employee



Aashir Awan

Employee



Abbas Shivji

Employee



abdellatif ziane

Employee



Aditya Singh

Employee



Adrian van Alphen

Employee



Adriana Oreskovic

Employee



Agustina Yornet

Employee



Aisling Glennie

Employee



Alan Davis

Employee



Alan Wong

Employee



Albert Lens

Employee



Alberto Delmoral

Employee



Alceu Rodrigues de Freitas Junior

Employee



Alejandro Medici

Employee



Alejandro Piris

Employee



Alex Lincoln-Dodgson

Employee



Alex Pavlenko

Employee



Alexander Dross

Employee



Alicia Alonso- Boyanowski M.Ed

Employee



Alison Chiaramonte

Employee



Alison Fay

Employee



Ana Serafimovic

Employee



Andika Tyastono

Employee



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









News

Title
Author
Date
Publisher
Description
June 4, 2019
WebWire
, , , , • New digital disease management program "Tiba Yako" breaks access and awareness barriers in hypertension and diabetes care, , • The mobile-based technology allows patients to monitor their blood pressure and blood glucose levels at home, digitally sending the results to their doctor , , • Tiba Yako is an integrated disease service model that will offer benefits to patients, healthcare providers and payers alike , , • There is an unmet need for efficient affordable and widely accessible ca...
May 16, 2019
WebWire
Boehringer Ingelheim uses digital technologies along the entire value chain to discover the medications and healthcare solutions of the future. Collaboration with start-ups and other drivers of innovation is playing an increasingly important role, so Boehringer Ingelheim, a family-owned company, is complementing its internal expertise specifically by cooperating with external parties for research and development, production, and patient care. More than 150 cooperative projects are ongoing...
Research and Markets
Invalid Date
www.prnewswire.com:443
DUBLIN, Feb. 12, 2019 /PRNewswire/ -- The "Global Equine Healthcare Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key...